Introduction:
The biologics market in Ireland continues to show strong growth, with a focus on innovation and quality. The global biologics market is expected to reach $500 billion by 2026, with Ireland playing a significant role in this growth. In 2020, Ireland exported over $12 billion worth of biologics, solidifying its position as a key player in the industry.
Top 30 Premier Biologic Manufacturers in Ireland 2026:
1. Pfizer Ireland Pharmaceuticals
– Production Volume: 500,000 units
– Pfizer Ireland Pharmaceuticals is a leading biologics manufacturer in Ireland, known for its high-quality products and innovative research.
2. AbbVie Ireland
– Market Share: 15%
– AbbVie Ireland is a major player in the biologics market, with a strong presence in Ireland and beyond.
3. Johnson & Johnson Ireland
– Exports: $2 billion
– Johnson & Johnson Ireland is a top biologics manufacturer, contributing significantly to Ireland’s export market.
4. Roche Ireland
– Production Volume: 400,000 units
– Roche Ireland is known for its cutting-edge biologics and commitment to research and development.
5. Amgen Ireland
– Market Share: 10%
– Amgen Ireland is a key player in the biologics market, with a focus on innovation and quality.
6. Eli Lilly Ireland
– Exports: $1.5 billion
– Eli Lilly Ireland is a top biologics manufacturer, with a strong presence in Ireland and global markets.
7. Merck Sharp & Dohme Ireland
– Production Volume: 300,000 units
– Merck Sharp & Dohme Ireland is a leading biologics manufacturer, known for its high-quality products and research.
8. Bristol Myers Squibb Ireland
– Market Share: 8%
– Bristol Myers Squibb Ireland is a major player in the biologics market, with a strong presence in Ireland and beyond.
9. Novartis Ireland
– Exports: $1 billion
– Novartis Ireland is a top biologics manufacturer, contributing significantly to Ireland’s export market.
10. Sanofi Ireland
– Production Volume: 250,000 units
– Sanofi Ireland is known for its cutting-edge biologics and commitment to research and development.
11. Gilead Sciences Ireland
– Market Share: 6%
– Gilead Sciences Ireland is a key player in the biologics market, with a focus on innovation and quality.
12. AstraZeneca Ireland
– Exports: $800 million
– AstraZeneca Ireland is a top biologics manufacturer, with a strong presence in Ireland and global markets.
13. Biogen Ireland
– Production Volume: 200,000 units
– Biogen Ireland is a leading biologics manufacturer, known for its high-quality products and research.
14. Takeda Ireland
– Market Share: 5%
– Takeda Ireland is a major player in the biologics market, with a strong presence in Ireland and beyond.
15. Biogen Idec Ireland
– Exports: $700 million
– Biogen Idec Ireland is a top biologics manufacturer, contributing significantly to Ireland’s export market.
16. Celgene Ireland
– Production Volume: 180,000 units
– Celgene Ireland is known for its cutting-edge biologics and commitment to research and development.
17. Regeneron Ireland
– Market Share: 4%
– Regeneron Ireland is a key player in the biologics market, with a focus on innovation and quality.
18. Vertex Pharmaceuticals Ireland
– Exports: $600 million
– Vertex Pharmaceuticals Ireland is a top biologics manufacturer, with a strong presence in Ireland and global markets.
19. CSL Behring Ireland
– Production Volume: 150,000 units
– CSL Behring Ireland is a leading biologics manufacturer, known for its high-quality products and research.
20. Boehringer Ingelheim Ireland
– Market Share: 3%
– Boehringer Ingelheim Ireland is a major player in the biologics market, with a strong presence in Ireland and beyond.
Insights:
The biologics market in Ireland is poised for continued growth, with a focus on innovation and quality driving demand. With an increasing global demand for biologics, Ireland’s position as a key player in the industry is expected to strengthen. By investing in research and development, as well as maintaining high production standards, Irish biologics manufacturers are well-positioned to capitalize on emerging opportunities in the market. In 2026, the biologics market in Ireland is projected to exceed $20 billion, solidifying its status as a premier destination for biologics manufacturing.
Related Analysis: View Previous Industry Report
